Oak hill bio

Altrincham, United Kingdom

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

$32.5M raised

Jun 2026

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oak hill bio raised?

Oak hill bio has raised $32.5M in total funding. The most recent round was Series A. The last funding was announced in June 2026.

Who are Oak hill bio's investors?

Oak hill bio's investors include Balyasny Asset Management, Janus Henderson Investors, venBio Partners, KCap Biotechnology Fund.

Where is Oak hill bio headquartered?

Oak hill bio is headquartered in Altrincham, United Kingdom.

What does Oak hill bio do?

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

What stage is Oak hill bio at?

Oak hill bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 1, 2026.

MLA

"Oak hill bio — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/oak-hill-bio. Accessed July 8, 2026.

APA

VCBacked. (2026). Oak hill bio — Funding & Investors. Retrieved July 8, 2026, from https://www.vcbacked.co/company/oak-hill-bio

Wikipedia (cite web)

{{cite web |title=Oak hill bio — Funding & Investors |url=https://www.vcbacked.co/company/oak-hill-bio |website=VCBacked |access-date=July 8, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 1, 2026.